Hans Aerni

Hans Aerni has over 20 years of work experience in the field of chemistry. Hans began their career in 1991 as a Chemistry Intern at The Swiss NBC Defense Establishment, where they acquired a variety of skills such as NMR spectroscopy, atomic absorption spectroscopy, metal analysis, and more. In 1999, they moved on to become a Research Scientist at EAWAG, where they developed an ultra-sensitive method for the analysis of steroids in wastewater and surface water. From 2002 to 2011, they worked at Vanderbilt University, first as a Graduate Student and then as a Research Assistant, where they developed sample coating technologies for MALDI Imaging MS and analyzed clinical tissue specimens. From 2011 to 2016, they were a Postdoc at Yale University, where they used quantitative mass spectrometry to characterize a genomically engineered organism and newly developed orthogonal translation systems for site-specific incorporation of non-standard amino acids. From 2016 to 2021, they were a Scientist I, Scientist II, and Principal Scientist at Synthorx Inc. Hans is currently employed as the Senior Director of CMC Analytical Development at Janux Therapeutics.

Hans Aerni obtained a Doctor of Philosophy (PhD) from Vanderbilt University in 2011, with a focus on bioanalytical mass spectrometry and protein marker discovery in clinical tissue specimen. Prior to this, they earned a Bachelor's Degree in Analytical Chemistry from HTA-BE Hochschule für Technik und Architektur Bern in 1999.